Renowned hospital and health system innovator brings four decades of operational, clinical, and technology strategy expertise to support Glooko’s next phase of growth
PALO ALTO, Calif.–(BUSINESS WIRE)–Glooko, Inc. a global leader in connected care and glycemic management solutions, today announced the appointment of Mark Laret, one of the nation’s leading healthcare operators and strategists, to its Board of Directors.
“As healthcare moves toward a more connected, data-driven future, health systems need partners who understand both the complexities of inpatient workflows and the realities of outpatient glycemic management,” said Mike Alvarez, Chief Executive Officer of Glooko. “Mark has operated at the highest levels of healthcare leadership and has a rare ability to blend operational discipline with innovation. His insights will be invaluable as we expand our footprint across the continuum of care and accelerate our growth globally.”
Laret brings more than 40 years of executive leadership experience across three major academic medical centers, including more than 20 years as President and Chief Executive Officer of UCSF Health. Under his leadership, UCSF transformed from a single medical center into one of the country’s most prominent regional health systems, doubling inpatient volume, increasing outpatient visits nearly fivefold, tripling its workforce, and achieving two decades of “Top 10 U.S. Hospital” rankings by U.S. News & World Report. He has also chaired the Association of American Medical Colleges, the Council of Teaching Hospitals, and the California Hospital Association, prominent organizations that help shape national healthcare policy and operational standards.
A nationally recognized voice in healthcare quality, safety, equity and patient experience, Laret also serves on the boards of several leading healthcare and health-tech organizations including Viz.ai, Collective Health, Blue Cross Blue Shield of Arizona, Regard, and the California Health Care Foundation. He has previously served on public company boards including Nuance Communications (acquired by Microsoft) and Varian Medical Systems (acquired by Siemens).
“Throughout my career, I’ve looked for organizations committed to improving quality, safety, and patient experience across both acute and ambulatory settings,” said Mark Laret. “Glooko sits at the nexus of two urgent needs: enabling clinicians to deliver more precise, efficient care and empowering patients to better manage chronic conditions. With Glooko’s expanded portfolio, including its recent advancement into inpatient glycemic management, I’m excited to support the team as it scales its impact and strengthens partnerships with health systems around the world.”
Laret’s background leading both inpatient and outpatient expansion aligns directly with Glooko’s strategic direction following its acquisition of Monarch Medical Technologies and its continued investment in connected care. His experience building complex health systems, scaling clinical operations, and advancing care transformation across diverse institutions and settings will deepen Glooko’s ability to deliver integrated solutions from hospital to home.
About Glooko
Glooko is a global portfolio of companies advancing intelligent connected diabetes and glycemic care across the care continuum. Through its offerings, Glooko is the only organization delivering integrated support from hospital to home. Together, these capabilities empower patients, healthcare providers, and health systems with data-driven tools that improve outcomes, simplify workflows, and scale care across inpatient and outpatient care settings.
Contacts
Media Contact:
Julia Fuller
Vice President, Corporate Communications
[email protected]
858-692-2001
